LOCAL NEWS:: The 151st Kalai Rai Balma Panda will be held in Jamir Chhara village | BJP indigenous MLA Ram Pada Jamatia wants CAB in Tripura | Dr Satyadeo appointed as VC of MBB College | Man arrested for raping, burning minor | NATIONAL NEWS:: UTI Dynamic Bond Fund | BJP ousts Congress in Hariyana and Maharashtra |

Go to Homepage Set as homepage Bookmark neindia
 Go to Homepage    
New Page 1
Home
News
Photo Gallery
Fashion
Features
Interview
Tenders
Notice for Interview of Field Assistant & Artist, Department of Industries & Commerce.

Click to visit
Tripura Artist Directory

Click to see recent jobs

 READ FASHION STORY # 32
Open a Printable Version      
Strides gets US approvals for Methotrexate Injection (3/30/2012) 
Bangalore, Mar 30 (IBNS): Onco Therapies Limited, a wholly owned subsidiary of pharmaceutical company Strides Arcolab Limited (Strides), on Friday announced that it has received US FDA approvals for Methotrexate Injection.

The approvals were received for Methotrexate Injection USP 25 mg/ mL packaged in 1 gram/ 40 m, 50 mg/2 mL, 100 mg / 4 mL, 200 mg/ 8 mL and 250 mg / 10 mL Single dose vials (preservative-free).

Methotrexate is amongst the products in the drug shortage list of US FDA.

According to IMS data, the US market for generic Methotrexate is approximately USD 13 Million.

It is part of the Oncology portfolio licensed to Pfizer in January 2010 for the US market and expected to be launched shortly.

Methotrexate is a chemotherapy drug used either alone or in combination with other agents.

It is used as a treatment for some autoimmune diseases including: rheumatoid arthritis, psoriasis, psoriatic arthritis, lupus and Crohn's disease, to name a few.
New Page 1   
Home
Home  |   Contact Us   |   Disclaimer

All rights reserved by neindia. Best viewed in Internet Explorer 6 and in 1280 X 720 resolutions

Count: New Page 1 1005445897